ClinicalTrials.Veeva

Menu

Mobility Opportunities Via Education/Experience (MOVE): Healthcare Impact Assessment

C

Center for Disability Services, New York

Status

Enrolling

Conditions

Quality of Life
Health Care Utilization

Treatments

Other: MOVE Program

Study type

Observational

Funder types

Other

Identifiers

NCT05862662
21-003 Rev. B

Details and patient eligibility

About

The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities.

Full description

The purpose of this study is to determine whether participation in the Mobility Opportunities Via Education (MOVE) program is associated with reduced use of healthcare for individuals with developmental disabilities. The investigators will compare healthcare "events" and healthcare expenditures for children and adults during intervals of at least one year when the subjects were participating in the MOVE program versus intervals of at least one year when the same individuals were not participating in the MOVE program based on health insurance records (i.e. Medicaid). Healthcare events are those which required professional medical services (associated with International Classification of Disease (ICD-XX) codes) or prescription medications. Healthcare events and healthcare expenditures will be reviewed from healthcare records obtained by Medicaid, Medicare, or private insurers and data will be compared between intervals.

Enrollment

130 estimated patients

Sex

All

Ages

5 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

CHILDREN: Inclusion Criteria

  • Males and females 5-21 years old.
  • Participated in the MOVE program pre-COVID and post-COVID.
  • Did not participate for at least 4 months in the MOVE program during COVID.
  • Has a healthcare payor(s) who makes healthcare records available upon request.
  • Subjects whose legal guardians are willing to give informed consent to obtain and review healthcare records from the subject's primary (and secondary, if applicable) payors.

CHILDREN: Exclusion Criteria

  • Subjects who did not participate in the MOVE program through the duration of Interval #1 and Interval #3.
  • Subjects whose legal guardians are unwilling to cooperate with the requests to obtain and review healthcare records and expenditures from the subject's primary (and secondary, if applicable) payors.

ADULTS: Inclusion Criteria

  • Males and females 22-65 years old.
  • Participated in the MOVE program during Interval #1 and Interval #3.
  • Did not participate for at least 4 months in the MOVE program during Interval #2.
  • Has a healthcare payor(s) who makes healthcare records available upon request.
  • Subjects who are willing to give informed consent and/or subjects' legal guardians who are willing to give informed assent to obtain and review healthcare records from the subject's primary (and secondary, if applicable) payors.

ADULTS: Exclusion Criteria

  • Subjects who did not participate in the MOVE program through the duration of Interval #1 and Interval #3.
  • Subjects who are unwilling to give informed consent and/or subjects' legal guardians who are unwilling to give informed assent to cooperate with the requests to obtain and review healthcare records and expenditures from the subject's primary (and secondary, if applicable) payors.

Trial design

130 participants in 2 patient groups

Children in MOVE Program
Description:
Children 5-12 years old who participated in the MOVE program for at least 12 continuous months prior to March 1, 2020 and again for at least 12 continuous months after August 2021.
Treatment:
Other: MOVE Program
Adults in MOVE Program
Description:
Adults 22-65 years old who participated in the MOVE program for at least 12 continuous months prior to March 1, 2020 and again for at least 12 continuous months after August 2021.
Treatment:
Other: MOVE Program

Trial contacts and locations

1

Loading...

Central trial contact

Eric H Ledet, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems